A Facebook for doctors? That’s what Doximity is being called. It started out as a LinkedIn for doctors, but with the addition of a news feed, it’s turning more Facebook-like. The company recently raked in $17 million series B round fundings. It was led by Morgenthaler Ventures, along with participation from Emergence Capital Partners and InterWest Partners.
This is the second round of funding that Doximity has received, which is when the company grew the most. It is a free, social networking tool that is secure and allows doctors to discuss patients, which cannot occur with regular social networks or text messaging. According to VentureBeat, Doximity
. . . hopes to connect doctors so that they can collaborate on cases, identify the right candidate for a referral, send private messages to each other, converse about the latest research, and gain exposure for their practice. It has experienced rapid expansion and recently announced that one in seven physicians in the United States have signed up.
Be sure to look for big things from this company in the future.
Boston-based startup Predilytics combines machine learning and health care to help health care companies run more efficiently. On September 4th, the company announced that it closed on a $6 million Series A round of funding. Contributors include Flybridge Capital Partners, Highland Capital Partners and Google Ventures.
Gigaoam.com quote Predilytics as describing their services as follows:
Predilytics offers a new approach for generating healthcare insights – applying big data, machine learning technology to create transparent, unbiased business driven results. This approach exceptional predictive models that are 2x to 4x more insightful and actionable than conventional statistical/regression modeling and rules-based methods.
Predilytics plans to use this funding to “further expand its product offerings and grow operations with a focus on analytics, information technology, application development and account management.”
InCrowd allows “pharmaceuticals to survey screened and targeted healthcare professionals in real-time.” The company recently closed a $2.2 million Series A round. The round was let by Nauta Capital.
InCrowd has a database of “pre-screened healthcare professionals.” These professionals have opted-in to being in the database. Pharmaceutical companies can take this database and find doctors that fit the description of who they want to to take their survey, and then a survey will be sent out to them.